Biosimilars As advocates for policies that support patient access to biosimilars, the Biosimilars Council, a division of the US trade group the Generic Pharmaceutical Association (GPhA), has said it is disappointed in the World Health Organization’s final proposal on the Biological Qualifier (BQ), which could be a barrier to competition from these new versions of critical medicines. 12 February 2016